Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct.

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

MARCH 15, 2025

For example, one of establishment psychiatrys most prominent researchers Kenneth Kendler noted in 2011, Although the DHS stimulated much science, most efforts to empirically validate it have failed. Nonetheless, the DHS has held the status of a scientific paradigm defended by some with great avidity.

Neurotransmitters and mental health 67

Neurotransmitters and mental health Manufacturing Trauma and the brain Pharmaceuticals 67

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145